Showing 1 - 2 results of 2 for search 'Alexis Duncan', query time: 0.01s Refine Results
  1. 1
    Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.

    Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study. by Mark J Hamilton, Yvonne Robb, Sarah Cumming, Helen Gregory, Alexis Duncan, Monika Rahman, Anne McKeown, Catherine McWilliam, John Dean, Alison Wilcox, Maria E Farrugia, Anneli Cooper, Josephine McGhie, Berit Adam, Richard Petty, Scottish Myotonic Dystrophy Consortium, Cheryl Longman, Iain Findlay, Alan Japp, Darren G Monckton, Martin A Denvir

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD)

    Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD) by Raymond A. Ng, Susanna Barratt, Alison Parisian, Gopinath S. Palanisamy, Samiron Phukan, Richard Sun, Brandon Robello, Guadalupe Peña, Judevin Sapugay, David Yeghikyan, Chenbo Wang, Samir Satish Kher, Srinivasan Thangathirupathy, Robert Millikin, Guijun Yu, Teruki Watanabe, Fei Zhou, Brian Rich, Alexis Duncan, Samuel E. Andersen, Reena Chawla, David R. Zak, Dirk A. Heerding, Brian R. Hearn, Geoffrey Greene, Cyrus L. Harmon, Leslie Hodges-Gallagher, Peter J. Kushner, Sean W. Fanning, David C. Myles

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: